Previous 10 | Next 10 |
Avanos Medical (NYSE:AVNS) is scheduled to announce Q1 earnings results on Wednesday, May 4th, before market open. The consensus EPS Estimate is $0.26 (+13.0% Y/Y) and the consensus Revenue Estimate is $197.8M (+9.3% Y/Y). Over the last 2 years, AVNS has beaten EPS estimates 75% of the time a...
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2022 Financial Results PR Newswire ALPHARETTA, Ga. , April 27, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results an...
Avanos Medical, Inc. to Present at the Virtual KeyBanc 2022 Life Sciences & MedTech Investor Forum Avanos Medical, Inc. to Present at the Virtual KeyBanc 2022 Life Sciences & MedTech Investor Forum PR Newswire ALPHARETTA, Ga. , March 15, 2022 /PRNewsw...
At first glance, shares of Meridian Bioscience look quite affordable, especially considering recent growth. But investors need to pay attention to the likely temporary improvement caused by the COVID-19 pandemic. Adjusting for this, the company looks much more expensive than it do...
Avanos Medical, Inc. (AVNS) Q4 2021 Earnings Conference Call February 23, 2022 9:00 AM ET Company Participants Scott Galovan – Vice President, Corporate Strategy and Business Development Joe Woody – Chief Executive Officer Michael Greiner – Senior Vice President and Chief...
Avanos Medical press release (NYSE:AVNS): Q4 Non-GAAP EPS of $0.46 beats by $0.06. Revenue of $193.4M (+4.5% Y/Y) beats by $2.08M. The company expects FY2022 net sales to be between $830M to $850M (vs. consensus of $780.32M), which assumes organic growth between 3% to 6%. Gross profit margins...
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2021 Results PR Newswire ALPHARETTA, Ga. , Feb. 23, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2021 results. "We are happy wit...
Avanos Medical (NYSE:AVNS) is scheduled to announce Q4 earnings results on Wednesday, February 23rd, before market open. The consensus EPS Estimate is $0.40 (+42.9% Y/Y) and the consensus Revenue Estimate is $191.32M (+3.4% Y/Y). Over the last 2 years, AVNS has beaten EPS estimates 75% of the...
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2021 Financial Results PR Newswire ALPHARETTA, Ga. , Feb. 15, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial...
Avanos Medical, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference PR Newswire ALPHARETTA, Ga. , Jan. 10, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at t...
News, Short Squeeze, Breakout and More Instantly...
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2024 Financial Results PR Newswire ALPHARETTA, Ga. , July 24, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and busine...
2024-07-19 23:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Avanos Medical, Inc. Appoints Indrani Franchini to Board of Directors PR Newswire ALPHARETTA, Ga. , July 1, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Indrani Franchini has been appointed as a new independent member of the Ava...